By NOF, WASHINGTON, DC; Thursday, March 11, 2010

Statement by National Osteoporosis Foundation Regarding the Use of Bisphosphonates

WASHINGTON, D.C. (March 11, 2010) — As the nation's leading voluntary health organization solely dedicated to osteoporosis and bone health, the National Osteoporosis Foundation (NOF) is committed to providing a breadth of information and resources on a range of issues from lifestyle behaviors to treatment options to help patients and health professionals throughout the country make informed decisions about bone health and osteoporosis. Because of that commitment, NOF offers the following statement on the recent news coverage of bisphosphonate medicines.

NOF recognizes that certain serious conditions associated with bisphosphonate medicines may cause concern for people taking these medicines. There have been reports of atrial fibrillation, osteonecrosis of the jaw (ONJ), severe pain and unusual broken bones in the thigh bone. While these conditions are serious, the number of people with them remains extremely small compared to the number of people who have taken these medicines. It is not really known whether the medications are even causing these problems, in part because the problems are so rare.

Based on information that is currently available, NOF believes that for most people taking bisphosphonate medicines, the benefits outweigh the risks of these unusual but serious conditions that appear to be associated with them. These medicines play an important role in stopping bone loss and preventing broken bones. Osteoporosis causes broken bones that result in significant pain, disability and loss of independence. Half of all women and up to one in four men over the age of 50 will break a bone due to osteoporosis. More than 20 percent of patients age 50 and older who break a hip die within one year. Many others never fully recover.

Research studies clearly show that people taking a medicine to treat osteoporosis reduce their chance of breaking a bone. Studies have found that bisphosphonates reduce the risk of a broken hip in people with osteoporosis by as much as 40 to 50 percent. These medicines also reduce the risk of other broken bones. Patients for whom bisphosphonates are appropriate would be at higher risk of breaking a bone without treatment.

All medicines have possible benefits and risks. It is the position of NOF that bisphosphonates are highly effective in the right patients and that patients should not discontinue use of these medicines without speaking to their healthcare professional. Patients should talk to their healthcare professional if they develop new pain or have any concerns with their medications. If you have osteoporosis or an increased chance of breaking a bone, always talk with your doctor or other healthcare provider about the treatment choices available to you.

Reviewing Your Treatment Plan

If you are taking an osteoporosis medicine, it is important that you review your treatment plan every year with your doctor or other healthcare provider. If you have been taking an osteoporosis medicine for five years, discuss the benefits of continuing it.

People who are not at high risk of breaking a bone may be able to take a "drug holiday" after five years of treatment with bisphosphonates. This means that you stop taking your osteoporosis medicine (bisphosphonate) but continue to see your healthcare provider to monitor your bone health, and look forward to restarting it at some point in the future. This does not apply to other medicines given for osteoporosis.

If you are at high risk of breaking a bone, then you may benefit by staying on an osteoporosis medicine. Other people may benefit from switching to a different medicine. Your healthcare provider is the best person to guide you about whether you should start, continue, switch or stop an osteoporosis medicine. Again, it is always important to look at both the benefits and risks of taking a medicine.

Reporting Unusual Symptoms

If you have side effects or unusual symptoms, be sure to report these to your doctor or other healthcare provider. If you have an unusual ache or pain in your hip or thigh bone, it's important to tell your healthcare provider. There have been rare reports of people having an ache or pain, sometimes for several weeks or even months, before having an unusual break in the femur (thigh bone).

What More You Can Do

For an osteoporosis medicine to work, you also need to get enough calcium and vitamin D. Eat a balanced diet that includes fruits, vegetables and calcium-rich foods. Adults under age 50 need 1,000 mg of calcium and 400-800 IU of vitamin D a day. Adults age 50 and older need 1,200 mg of calcium and 800-1,000 IU of vitamin D a day. Regular exercise and physical activity are also necessary to have healthy bones. Try to make exercise a part of your daily routine. In addition, avoid smoking and limit your alcohol intake to no more than 2 drinks per day.

About National Osteoporosis Foundation

Established in 1984, the National Osteoporosis Foundation, a leading community-focused health organization, is dedicated to the prevention of osteoporosis and broken bones, the promotion of strong bones for life and the reduction of human suffering through programs of awareness, education, advocacy and research. For more information on the National Osteoporosis Foundation, visit visit www.nof.org.

The latest

Last week, a Food and Drug Administration (FDA) Panel voted that the risks of calcitonin salmon outweigh the benefits for the treatment of postmenopausal osteoporosis. The panel joined health authorities around the world in reviewing the drug’s safety after two recent studies showed slightly higher rates of cancer among patients taking calcitonin. The panel voted against continued use of the drug by a narrow majority, pointing out that it has not been found very effective in preventing bone fractures.

In today's Washington Post article "Calcium and Vitamin D findings show that caring for your bones can be compilicated," NOF's senior clinical director, Dr. Felicia Cosman helps clear up some of the confusion around the recent and conflicting research on calcium and vitamin D. She says: "It’s confusing, even for doctors. But there’s a common thread: None of the heart or kidney risks were associated with calcium from food."

CIRCA, the leading international buyer of fine jewelry, diamonds and watches, announced a new partnership with NOF at a Generations of Strength luncheon at the Friars Club in New York City on February 26. To kick-off the partnership, CIRCA’s Acting CEO Mary L. Forté presented NOF Executive Director and CEO Amy Porter with a check for $25,000, to support NOF’s mission.